Timothy McAlindon to Clinical Trials as Topic
This is a "connection" page, showing publications Timothy McAlindon has written about Clinical Trials as Topic.
Connection Strength
0.658
-
McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, Wang S, Schnitzer T. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthritis Cartilage. 2015 May; 23(5):747-60.
Score: 0.385
-
McAlindon TE, Bannuru RR. Osteoarthritis in 2017: Latest advances in the management of knee OA. Nat Rev Rheumatol. 2018 02; 14(2):73-74.
Score: 0.116
-
Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part I, review of the clinical evidence. Med Health R I. 2004 Jun; 87(6):176-9.
Score: 0.045
-
McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am. 2003 Nov; 29(4):789-801.
Score: 0.043
-
McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000 Mar 15; 283(11):1469-75.
Score: 0.034
-
Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007 Jul; 56(7):2267-77.
Score: 0.014
-
Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003 Dec 17; 290(23):3115-21.
Score: 0.011
-
LaValley M, McAlindon TE, Evans S, Chaisson CE, Felson DT. Problems in the development and validation of questionnaire-based screening instruments for ascertaining cases with symptomatic knee osteoarthritis: the Framingham Study. Arthritis Rheum. 2001 May; 44(5):1105-13.
Score: 0.009